Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
1 clinical trials · Condition
◉ Watch Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
| Record | Firm | Date |
|---|---|---|
| Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis (NCT07712536) | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | 2025-06-04 |
Track Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD) automatically
Every clearance here is in the API, with alerts when new ones post.